At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Creatine Monohydrate Use and Muscle Stretching in Peripheral Artery Disease
In Brief
A Phase 2 clinical trial evaluating Creatine monohydrate and Cellulose for Peripheral Arterial Disease. Completed, enrolled 13 participants across 1 site.
Detailed Summary
To utilize near-infrared spectroscopy to investigate if the research device, which induces muscle stretching, and creatine loading impact submaximal exercise performance in aged and PAD patients. Near-infrared spectroscopy (NIRS)-derived tissue oxygenation responses will be obtained during device placement (muscle stretch) and during a walking test (i.e., six-minute walk test). Muscle oxygenation at rest and during device placement will be assessed with Magnetic Resonance Imaging. It is hypothesized that the stretching protocol will improve both NIRS-derived tissue oxygenation and magnetic resonance-derived muscle oxygenation and that creatine supplementation will further improve phosphorus metabolite muscle performance. All patients will undergo either 4 weeks of stretch training with- or- without creatine supplementation according to previously defined creatine guidelines.
Study Details
Timeline
Interventions
Creatine monohydrate will be used in combination with muscle stretching.
Cellulose will be used in combination with muscle stretching.